Fedenia Advisers »

Regeneron Pharmaceuticals shares owned by Fedenia Advisers

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Fedenia Advisers from 13F filings

Historical chart of Fedenia Advisers investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Fedenia Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Fedenia Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $47k 75 623.55

More positions owned by Fedenia Advisers

Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr S&p 500 Etf Etf (SPY)
Ishares National Muni Bond Etf Etf (MUB)
Sandisk Corp Stock (SNDK)
Vanguard S&p 500 Etf Etf (VOO)
Micron Technology Stock (MU)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Western Digital Corp Stock (WDC)
Advanced Micro Devices Stock (AMD)
Seagate Technology Hldngs Plc Ord Stock (STX)
Lam Research Corp Stock (LRCX)
Marvell Technology Stock (MRVL)
Applied Matls Stock (AMAT)
Palo Alto Networks Stock (PANW)
Ishares Long-term National Muni Bond Etf Etf (LMUB)

View all positions for Fedenia Advisers

Top funds holding Regeneron Pharmaceuticals

BlackRock
Vanguard Capital Management
Dodge & Cox
State Street Corporation
Invesco
Jpmorgan Chase & Co
Vanguard Portfolio Management
Franklin Resources
Geode Capital Management
T. Rowe Price Associates
Nuveen
Loomis, Sayles and
Capital World Investors
Goldman Sachs Group
Morgan Stanley

View all funds holding Regeneron Pharmaceuticals